Skip to main content

Table 1 Characteristics between survivors and non-survivors with COVID-19

From: Clinical determinants for fatality of 44,672 patients with COVID-19

CharacteristicsTotal (n = 44,672)Non-survivors (n = 1023)Survivors (n = 43,649)Fatality (%)RR (95%CI)p
Age, n (%)
 0–416 (0.9%)0416 (0.9%)0  
 10–549 (1.2%)1 (0.1%)548 (1.3%)0.2  
 20–3619 (8.1%)7 (0.7%)3612 (8.3%)0.2  
 30–7600 (17.0%)18 (1.8%)7582 (17.4%)0.2  
 40–8571 (19.2%)38 (3.7%)8533 (19.5%)0.4  
 50–10,008 (22.4%)130 (12.7%)9878 (22.6%)1.3  
 60–8583 (19.2%)309 (30.2%)8274 (19.0%)3.6  
 70–3918 (8.8%)312 (30.5%)3606 (8.3%)8.0  
 ≥ 801408 (3.2%)208 (20.3%)1200 (2.7%)14.8  
Severity*, n (%)
 Mild/moderate36,160 (80.9%)036,160 (82.8%)0  
 Severe6168 (13.8%)06168 (14.1%)0  
 Critical2087 (4.7%)1023 (100%)1064 (2.4%)49.0  
Gender, n (%)
 Male22,981 (51.4%)653 (63.8%)22,328 (51.2%)2.81.67 (1.47–1.89)< 0.001
 Female21,691 (48.6%)370 (36.2%)21,321 (48.8%)1.7  
Comorbidity#, n (%)
 Hypertension2683 (12.8%)161 (39.7%)2522 (12.3%)6.04.48 (3.69–5.45)< 0.001
 Diabetes1102 (5.3%)80 (19.7%)1022 (5.0%)7.34.47 (3.49–5.61)< 0.001
 Cardiovascular disease873 (4.2%)92 (22.7%)781 (3.8%)10.56.75 (5.40–8.43)< 0.001
 Respiratory disease511 (2.4%)32 (7.9%)479 (2.3%)6.33.43 (2.42–4.87)< 0.001
 Cancer107 (0.5%)6 (1.5%)101 (0.5%)5.62.93 (1.34–6.41)0.006
  1. *Missing data (n = 257 in survivors group)
  2. #Missing data (n = 617 in the non-survivors group, n = 23,073 in the survivors group)